National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

indium In 111 chimeric monoclonal antibody 806
A recombinant chimeric, mouse-human monoclonal antibody IgG1, directed against the epidermal growth factor receptor (EGFR) and labeled with the radioisotope indium-111, with potential radioimaging activity. Indium 111 chimeric monoclonal antibody 806 binds to a specific epitope on EGFR-expressing tumor cells, allowing imaging of EGFR-expressing tumor cells using gamma scintigraphy. EGFR is a receptor tyrosine kinase that is involved in the regulation of cell growth and is found to be overexpressed on the cell surfaces of many tumor cell types. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Abbreviation:111-Indium-ch806



Previous:indibulin, indicine-N-oxide, indinavir sulfate, indium I 111 bevacizumab, indium I 111 chimeric monoclonal antibody G250
Next:indium In 111 CHX-A DTPA trastuzumab, indium In 111 ibritumomab tiuxetan, indium In 111 monoclonal antibody BrE-3, indium In 111 monoclonal antibody huPAM4, indium In 111 pentetate

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov